Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Strabismus | 31 | 2024 | 317 | 10.270 |
Why?
|
Oculomotor Muscles | 32 | 2024 | 406 | 6.780 |
Why?
|
Craniosynostoses | 15 | 2023 | 412 | 6.090 |
Why?
|
Ophthalmologic Surgical Procedures | 27 | 2024 | 354 | 5.190 |
Why?
|
Esotropia | 8 | 2024 | 99 | 3.010 |
Why?
|
Vision, Binocular | 18 | 2024 | 226 | 2.550 |
Why?
|
Exotropia | 6 | 2023 | 64 | 2.350 |
Why?
|
Ocular Motility Disorders | 6 | 2022 | 144 | 2.240 |
Why?
|
Optic Atrophy | 3 | 2023 | 79 | 2.120 |
Why?
|
Oculomotor Nerve Diseases | 6 | 2023 | 54 | 1.960 |
Why?
|
Amblyopia | 5 | 2023 | 150 | 1.780 |
Why?
|
Graves Ophthalmopathy | 5 | 2018 | 133 | 1.720 |
Why?
|
Eye Movements | 9 | 2022 | 511 | 1.700 |
Why?
|
Duane Retraction Syndrome | 4 | 2020 | 59 | 1.570 |
Why?
|
Abducens Nerve Diseases | 3 | 2020 | 44 | 1.490 |
Why?
|
Diplopia | 8 | 2023 | 214 | 1.430 |
Why?
|
Intracranial Hypertension | 2 | 2023 | 193 | 1.290 |
Why?
|
Astigmatism | 3 | 2023 | 68 | 1.200 |
Why?
|
Eye Injuries | 2 | 2019 | 227 | 0.870 |
Why?
|
Mobius Syndrome | 1 | 2021 | 41 | 0.770 |
Why?
|
Suture Techniques | 4 | 2020 | 768 | 0.670 |
Why?
|
Antiemetics | 1 | 2020 | 186 | 0.620 |
Why?
|
Electric Power Supplies | 1 | 2019 | 95 | 0.610 |
Why?
|
Cranial Sutures | 3 | 2019 | 92 | 0.610 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2023 | 1875 | 0.610 |
Why?
|
Sclera | 2 | 2017 | 190 | 0.610 |
Why?
|
Eye Infections, Fungal | 1 | 2019 | 100 | 0.590 |
Why?
|
Skull | 2 | 2019 | 818 | 0.580 |
Why?
|
Goals | 3 | 2023 | 708 | 0.580 |
Why?
|
Scleral Diseases | 1 | 2017 | 22 | 0.570 |
Why?
|
Lenses | 1 | 2017 | 42 | 0.560 |
Why?
|
Central Serous Chorioretinopathy | 1 | 2017 | 27 | 0.560 |
Why?
|
Retinal Ganglion Cells | 3 | 2023 | 810 | 0.560 |
Why?
|
Aspergillosis | 1 | 2019 | 242 | 0.550 |
Why?
|
Retrospective Studies | 35 | 2024 | 80566 | 0.550 |
Why?
|
Dystonia | 1 | 2020 | 370 | 0.550 |
Why?
|
Optic Nerve | 2 | 2021 | 572 | 0.540 |
Why?
|
Vision Tests | 1 | 2017 | 161 | 0.540 |
Why?
|
Scleral Buckling | 1 | 2017 | 95 | 0.540 |
Why?
|
Optic Nerve Diseases | 1 | 2019 | 342 | 0.500 |
Why?
|
Nerve Fibers | 2 | 2019 | 707 | 0.490 |
Why?
|
Abscess | 1 | 2019 | 606 | 0.490 |
Why?
|
Trochlear Nerve Diseases | 2 | 2018 | 15 | 0.480 |
Why?
|
Foreign Bodies | 1 | 2019 | 402 | 0.470 |
Why?
|
Visual Acuity | 9 | 2024 | 2672 | 0.470 |
Why?
|
Propofol | 1 | 2020 | 602 | 0.470 |
Why?
|
Infant | 20 | 2023 | 36152 | 0.460 |
Why?
|
Mandibulofacial Dysostosis | 1 | 2013 | 36 | 0.450 |
Why?
|
Orbital Fractures | 1 | 2014 | 109 | 0.430 |
Why?
|
Papilledema | 1 | 2014 | 130 | 0.430 |
Why?
|
Craniotomy | 2 | 2019 | 741 | 0.430 |
Why?
|
Retinal Detachment | 2 | 2017 | 428 | 0.430 |
Why?
|
Craniopharyngioma | 1 | 2016 | 276 | 0.420 |
Why?
|
Orbit | 6 | 2021 | 457 | 0.410 |
Why?
|
Pericardium | 1 | 2017 | 664 | 0.410 |
Why?
|
Cysts | 2 | 2016 | 680 | 0.400 |
Why?
|
Mucocele | 1 | 2012 | 51 | 0.400 |
Why?
|
Nose | 2 | 2022 | 521 | 0.400 |
Why?
|
Head Protective Devices | 1 | 2013 | 118 | 0.400 |
Why?
|
Orbital Diseases | 1 | 2013 | 178 | 0.390 |
Why?
|
Foreign-Body Migration | 1 | 2013 | 219 | 0.380 |
Why?
|
Interferon-alpha | 1 | 2016 | 902 | 0.380 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2012 | 72 | 0.380 |
Why?
|
Nasolacrimal Duct | 1 | 2012 | 79 | 0.380 |
Why?
|
Accidental Falls | 1 | 2019 | 1065 | 0.360 |
Why?
|
Tissue Adhesions | 1 | 2011 | 218 | 0.350 |
Why?
|
Amnion | 1 | 2011 | 197 | 0.350 |
Why?
|
Polyethylene Glycols | 1 | 2016 | 1182 | 0.340 |
Why?
|
Tomography, Optical Coherence | 3 | 2023 | 2916 | 0.340 |
Why?
|
Bone Screws | 1 | 2013 | 530 | 0.340 |
Why?
|
Ophthalmology | 2 | 2019 | 550 | 0.330 |
Why?
|
Humans | 67 | 2024 | 760617 | 0.330 |
Why?
|
Wounds, Penetrating | 1 | 2011 | 313 | 0.320 |
Why?
|
Synostosis | 1 | 2009 | 43 | 0.320 |
Why?
|
Titanium | 1 | 2011 | 485 | 0.310 |
Why?
|
Child, Preschool | 18 | 2024 | 42188 | 0.310 |
Why?
|
Vision Disorders | 1 | 2016 | 1088 | 0.310 |
Why?
|
Amaurosis Fugax | 1 | 2008 | 7 | 0.310 |
Why?
|
Child | 21 | 2024 | 80079 | 0.300 |
Why?
|
Antithyroid Agents | 1 | 2008 | 72 | 0.300 |
Why?
|
Endoscopy | 5 | 2019 | 1851 | 0.290 |
Why?
|
Pituitary Neoplasms | 1 | 2016 | 1323 | 0.280 |
Why?
|
Graves Disease | 1 | 2008 | 238 | 0.280 |
Why?
|
Ectopia Lentis | 1 | 2006 | 20 | 0.270 |
Why?
|
Lens Subluxation | 1 | 2006 | 23 | 0.270 |
Why?
|
Rheumatic Heart Disease | 1 | 2008 | 163 | 0.270 |
Why?
|
Visual Fields | 3 | 2019 | 1062 | 0.250 |
Why?
|
Follow-Up Studies | 14 | 2024 | 39063 | 0.240 |
Why?
|
Puberty | 1 | 2008 | 501 | 0.240 |
Why?
|
Prostheses and Implants | 1 | 2011 | 1269 | 0.230 |
Why?
|
Endocrinology | 1 | 2010 | 442 | 0.230 |
Why?
|
Male | 35 | 2024 | 360358 | 0.230 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2006 | 190 | 0.230 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 1790 | 0.230 |
Why?
|
Lens, Crystalline | 1 | 2006 | 387 | 0.230 |
Why?
|
Myopia | 1 | 2006 | 252 | 0.220 |
Why?
|
Blepharoplasty | 1 | 2024 | 61 | 0.220 |
Why?
|
Aortic Valve Insufficiency | 1 | 2008 | 576 | 0.220 |
Why?
|
Ophthalmoplegia | 2 | 2018 | 168 | 0.210 |
Why?
|
Postoperative Complications | 4 | 2024 | 15612 | 0.200 |
Why?
|
Syndrome | 3 | 2019 | 3268 | 0.200 |
Why?
|
Female | 30 | 2024 | 392148 | 0.190 |
Why?
|
Treatment Outcome | 13 | 2024 | 64568 | 0.190 |
Why?
|
Adolescent | 14 | 2024 | 88234 | 0.180 |
Why?
|
Incidence | 6 | 2024 | 21337 | 0.180 |
Why?
|
Adult | 19 | 2024 | 220969 | 0.180 |
Why?
|
Botulinum Toxins, Type A | 1 | 2024 | 238 | 0.180 |
Why?
|
Plagiocephaly | 1 | 2019 | 6 | 0.170 |
Why?
|
Ondansetron | 1 | 2020 | 95 | 0.170 |
Why?
|
Aspergillus | 1 | 2019 | 93 | 0.160 |
Why?
|
Siblings | 1 | 2023 | 824 | 0.160 |
Why?
|
Alopecia | 1 | 2023 | 412 | 0.150 |
Why?
|
Bupropion | 1 | 2020 | 304 | 0.150 |
Why?
|
Mitral Valve Insufficiency | 1 | 2008 | 1400 | 0.150 |
Why?
|
Growth Disorders | 1 | 2023 | 634 | 0.150 |
Why?
|
Orbital Implants | 1 | 2017 | 21 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9277 | 0.140 |
Why?
|
Academies and Institutes | 1 | 2019 | 318 | 0.140 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2019 | 251 | 0.140 |
Why?
|
Esthetics | 1 | 2019 | 327 | 0.140 |
Why?
|
Eye | 1 | 2021 | 712 | 0.140 |
Why?
|
Evoked Potentials, Visual | 1 | 2019 | 417 | 0.140 |
Why?
|
Cerebral Veins | 1 | 2017 | 157 | 0.130 |
Why?
|
Drug Administration Routes | 1 | 2016 | 150 | 0.130 |
Why?
|
Infant, Newborn | 4 | 2023 | 26180 | 0.130 |
Why?
|
Severity of Illness Index | 4 | 2017 | 15828 | 0.120 |
Why?
|
Young Adult | 8 | 2019 | 59179 | 0.120 |
Why?
|
Torticollis | 1 | 2015 | 64 | 0.120 |
Why?
|
Frontal Bone | 2 | 2019 | 105 | 0.120 |
Why?
|
Tenotomy | 1 | 2014 | 55 | 0.120 |
Why?
|
Eyelids | 2 | 2024 | 278 | 0.110 |
Why?
|
Zygoma | 1 | 2013 | 52 | 0.110 |
Why?
|
Exophthalmos | 1 | 2014 | 97 | 0.110 |
Why?
|
Decision Trees | 1 | 2015 | 504 | 0.110 |
Why?
|
Baseball | 1 | 2014 | 95 | 0.110 |
Why?
|
Consensus | 2 | 2021 | 3117 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13635 | 0.100 |
Why?
|
Optic Nerve Glioma | 1 | 2012 | 32 | 0.100 |
Why?
|
Intracranial Pressure | 1 | 2014 | 324 | 0.100 |
Why?
|
Polysomnography | 1 | 2019 | 1849 | 0.100 |
Why?
|
Decompression, Surgical | 1 | 2017 | 606 | 0.100 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2017 | 841 | 0.100 |
Why?
|
False Positive Reactions | 1 | 2014 | 957 | 0.100 |
Why?
|
Postoperative Period | 1 | 2017 | 1813 | 0.100 |
Why?
|
Reoperation | 3 | 2019 | 4300 | 0.100 |
Why?
|
Iatrogenic Disease | 1 | 2014 | 538 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2023 | 3451 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 5 | 2017 | 20556 | 0.090 |
Why?
|
Diagnosis, Differential | 3 | 2013 | 12966 | 0.090 |
Why?
|
Paralysis | 2 | 2022 | 250 | 0.090 |
Why?
|
Optic Atrophies, Hereditary | 1 | 1990 | 27 | 0.090 |
Why?
|
Hereditary Sensory and Motor Neuropathy | 1 | 1990 | 21 | 0.090 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26049 | 0.090 |
Why?
|
Hyperopia | 1 | 1990 | 41 | 0.090 |
Why?
|
Eye Abnormalities | 1 | 2012 | 242 | 0.090 |
Why?
|
Blindness | 3 | 1990 | 584 | 0.080 |
Why?
|
Orthoptics | 2 | 2022 | 10 | 0.080 |
Why?
|
Penicillin V | 1 | 2008 | 18 | 0.080 |
Why?
|
Penicillin G Benzathine | 1 | 2008 | 25 | 0.080 |
Why?
|
Optic Disk | 1 | 2012 | 421 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2019 | 2067 | 0.070 |
Why?
|
Education | 1 | 2010 | 534 | 0.070 |
Why?
|
Middle Aged | 11 | 2024 | 220584 | 0.070 |
Why?
|
Aged | 8 | 2024 | 169042 | 0.070 |
Why?
|
Reflex, Abnormal | 1 | 1987 | 83 | 0.070 |
Why?
|
Convergence, Ocular | 2 | 2022 | 26 | 0.070 |
Why?
|
Catheterization | 1 | 2012 | 1428 | 0.070 |
Why?
|
Accommodation, Ocular | 2 | 2022 | 47 | 0.070 |
Why?
|
Delphi Technique | 2 | 2021 | 846 | 0.070 |
Why?
|
Gonioscopy | 1 | 2006 | 155 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2020 | 12334 | 0.070 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6520 | 0.070 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 1985 | 42 | 0.060 |
Why?
|
Acute Disease | 2 | 2024 | 7237 | 0.060 |
Why?
|
Retinal Artery | 1 | 1985 | 109 | 0.060 |
Why?
|
Anesthesia, General | 1 | 2012 | 1173 | 0.060 |
Why?
|
Stem Cells | 1 | 2017 | 3516 | 0.060 |
Why?
|
Echocardiography, Doppler | 1 | 2008 | 893 | 0.060 |
Why?
|
Granuloma | 1 | 1985 | 328 | 0.050 |
Why?
|
Prospective Studies | 3 | 2023 | 54360 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5789 | 0.050 |
Why?
|
Injections, Intramuscular | 1 | 2024 | 555 | 0.050 |
Why?
|
Neuromuscular Agents | 1 | 2024 | 148 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 36402 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2008 | 1265 | 0.050 |
Why?
|
Intraocular Pressure | 1 | 2006 | 1294 | 0.040 |
Why?
|
Radiography | 1 | 2011 | 6961 | 0.040 |
Why?
|
Stents | 1 | 2012 | 3178 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14648 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15251 | 0.040 |
Why?
|
Age Factors | 3 | 2011 | 18381 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2270 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6305 | 0.040 |
Why?
|
Transverse Sinuses | 1 | 2017 | 25 | 0.040 |
Why?
|
Edema | 1 | 2021 | 765 | 0.030 |
Why?
|
Aspirin | 1 | 2008 | 3127 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2017 | 277 | 0.030 |
Why?
|
United States | 2 | 2024 | 72272 | 0.030 |
Why?
|
Dura Mater | 1 | 2017 | 290 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58894 | 0.030 |
Why?
|
Neural Crest | 1 | 2017 | 279 | 0.030 |
Why?
|
Cerebral Arteries | 1 | 2017 | 490 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2019 | 636 | 0.030 |
Why?
|
Mesoderm | 1 | 2017 | 674 | 0.030 |
Why?
|
Boston | 1 | 2007 | 9313 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2017 | 1748 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23416 | 0.030 |
Why?
|
Risk Factors | 2 | 2014 | 74115 | 0.030 |
Why?
|
Aging | 1 | 2011 | 8699 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2019 | 1299 | 0.020 |
Why?
|
Osteoblasts | 1 | 2017 | 1141 | 0.020 |
Why?
|
Depth Perception | 1 | 2012 | 94 | 0.020 |
Why?
|
Mydriatics | 1 | 2011 | 67 | 0.020 |
Why?
|
Atropine | 1 | 2011 | 244 | 0.020 |
Why?
|
Sensory Deprivation | 1 | 2011 | 108 | 0.020 |
Why?
|
Head Movements | 1 | 2012 | 152 | 0.020 |
Why?
|
Ocular Physiological Phenomena | 1 | 1990 | 67 | 0.020 |
Why?
|
Eyeglasses | 1 | 2011 | 137 | 0.020 |
Why?
|
Disease Progression | 1 | 2006 | 13495 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2008 | 7402 | 0.020 |
Why?
|
Dominance, Cerebral | 1 | 1990 | 623 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8207 | 0.020 |
Why?
|
Prognosis | 1 | 2008 | 29600 | 0.020 |
Why?
|
Spasm | 1 | 1987 | 130 | 0.020 |
Why?
|
Pupil | 1 | 1987 | 145 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 1700 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6418 | 0.020 |
Why?
|
Scotoma | 1 | 1985 | 130 | 0.010 |
Why?
|
Infarction | 1 | 1985 | 248 | 0.010 |
Why?
|
Visual Field Tests | 1 | 1985 | 411 | 0.010 |
Why?
|
Visual Cortex | 1 | 1990 | 1105 | 0.010 |
Why?
|
Muscles | 1 | 1985 | 1573 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13347 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11514 | 0.010 |
Why?
|
Retinal Diseases | 1 | 1985 | 704 | 0.010 |
Why?
|
Thromboembolism | 1 | 1985 | 991 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 10199 | 0.010 |
Why?
|
Biopsy | 1 | 1985 | 6762 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 30016 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23972 | 0.010 |
Why?
|
Cohort Studies | 1 | 2014 | 41457 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81368 | 0.010 |
Why?
|
Electron Transport Complex IV | 1 | 1990 | 190 | 0.010 |
Why?
|
Animals | 1 | 2017 | 168201 | 0.000 |
Why?
|
Brain Mapping | 1 | 1990 | 6634 | 0.000 |
Why?
|
Concepts
(245)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_